Ziccum’s unique LaminarPace technology unleashes the full potential of mRNA and opens the door to entirely new mRNA treatments. This formulation and ambient drying technology transforms delicate liquid biologics into robust, thermostable, high-yield dry powders while preserving mRNA activity.
Join Ziccum at Nordic Life Science Days, meet with the Scientific Director Fabrice Rose to discover LaminarPace, review Ziccum’s solid and extensively validated data for mRNA/LNP and learn how key stability issues can be solved and new therapeutic possibilities created.
Book a meeting here: https://ziccum.com/about-us/contact/